Sfoglia per Autore
ERAPs Reduce In Vitro HIV Infection by Activating Innate Immune Response
2021 I. Saulle, I. Marventano, M. Saresella, C. Vanetti, M. Garziano, C. Fenizia, D.L. Trabattoni, M.S. Clerici, M. Biasin
MiRNA profiling in plasma and placenta of SARS-CoV-2-infected pregnant women
2021 I. Saulle, M. Garziano, C. Fenizia, G. Cappelletti, F. Parisi, M. Clerici, I. Cetin, V. Savasi, M. Biasin
Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature
2021 E. Torretta, M. Garziano, M. Poliseno, D. Capitanio, M. Biasin, T. Antonia Santantonio, M.S. Clerici, S. Lo Caputo, D.L. Trabattoni, C. Gelfi
Anti-inflammatory effects of diet and caloric restriction in metabolic syndrome
2021 L. Montefusco, F. D'Addio, C. Loretelli, M. Ben Nasr, M. Garziano, A. Rossi, I. Pastore, L. Plebani, M.E. Lunati, A.M. Bolla, M.D. Porta, G. Piuri, F. Rocchio, A. Abdelsalam, E. Assi, M. Barichella, A. Maestroni, V. Usuelli, L. Loreggian, F. Muzio, G.V. Zuccotti, R. Cazzola, P. Fiorina
Anti-inflammatory effects of immunostimulation in patients with covid-19 pneumonia
2021 P. Santus, D. Radovanovic, M. Garziano, S. Pini, G. Croce, G. Fuccia, D. Spitaleri, M. Biasin, M. Clerici, D. Trabattoni
Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees
2022 M. Garziano, O. Utyro, M. Poliseno, T.A. Santantonio, I. Saulle, S. Strizzi, S. Lo Caputo, M. Clerici, A. Introini, M. Biasin
Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein
2022 I. Varotto-Boccazzi, M. Garziano, G.M. Cattaneo, B. Bisaglia, P. Gabrieli, M. Biasin, A. Manenti, D. Rubolini, M. Clerici, E. Montomoli, G.V. Zuccotti, D. Trabattoni, S. Epis, C. Bandi
Dopamine Reduces SARS-CoV-2 Replication In Vitro through Downregulation of D2 Receptors and Upregulation of Type-I Interferons
2022 F. Limanaqi, S. Zecchini, B. Dino, S. Strizzi, G. Cappelletti, O. Utyro, C. Vanetti, M. Garziano, I. Saulle, M. Clerici, M. Biasin
Saliva and Plasma Neutralizing Activity Induced by the Administration of a Third bnt162b2 Vaccine Dose
2022 M. Garziano, O. Utyro, S. Strizzi, C. Vanetti, I. Saulle, C. Conforti, F. Cicilano, F. Ardizzone, G. Cappelletti, M. Clerici, F. Limanaqi, M. Biasin
Salivary miRNA Profiles in COVID-19 Patients with Different Disease Severities
2023 I. Saulle, M. Garziano, G. Cappelletti, F. Limanaqi, S. Strizzi, C. Vanetti, S. Lo Caputo, M. Poliseno, T. Santantonio, M. Clerici, M. Biasin
Human motor neurons derived from induced pluripotent stem cells are susceptible to SARS-CoV-2 infection
2023 G. Cappelletti, C. Colombrita, F. Limanaqi, S. Invernizzi, M. Garziano, C. Vanetti, C. Moscheni, S. Santangelo, S. Zecchini, D. Trabattoni, V. Silani, M. Clerici, A. Ratti, M. Biasin
Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
2024 C. Vanetti, M. Stracuzzi, E. Crivellaro, F. Ciciliano, M. Garziano, C. Fenizia, M. Biasin, V. Rubinacci, A. Amendola, E. Tanzi, G.V. Zuccotti, M. Clerici, V. Giacomet, D. Trabattoni
Alpha-synuclein dynamics bridge Type-I Interferon response and SARS-CoV-2 replication in peripheral cells
2024 F. Limanaqi, S. Zecchini, I. Saulle, S. Strizzi, C. Vanetti, M. Garziano, G. Cappelletti, D. Parolin, S. Caccia, D. Trabattoni, C. Fenizia, M. Clerici, M. Biasin
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile